HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,889.00
-211.00 (-10.05%)
At close: Jul 20, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 32.57 billion as of July 21, 2026. Its market cap has decreased by -74.23% in one year.
Market Cap
32.57B
Enterprise Value
37.31B
Revenue
73.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,889.00
ChartMarket Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 32.57B, a decrease of -87.20%. That is a compound annual growth rate of -26.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 32.52B | -73.53% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 225.35B |
| DreamCIS | 74.54B |
| P&K Skin Research Center | 50.46B |
| WOOJUNG BIO | 39.30B |
| SLS BIO | 26.89B |
| C&R Research | 22.69B |
| DT&CRO CO. | 21.85B |
| Curachem | 12.65B |